Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1 - PubMed

Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1

Xingxing Diao et al. Drug Metab Dispos. 2014 Apr.

Abstract

3-n-Butylphthalide (NBP) [(±)-3-butyl-1(3H)-isobenzofuranone] is an anti-cerebral-ischemia drug. Moderate hepatotoxicity has been observed in clinical applications. One of the major metabolites, 3-N-acetylcysteine-NBP, has been detected in human urine, indicating the formation of a reactive metabolite. We elucidated the formation mechanism of the reactive metabolite and its association with the hepatotoxicity of NBP. The in vitro incubations revealed that 3-glutathione-NBP (3-GSH-NBP) was observed only in fresh rat liver homogenate rather than in liver microsomes, liver cytosol, or liver 9,000g supernatant supplemented with NADPH and GSH. We also detected 3-GSH-NBP when 3'-phosphoadenosine-5'-phosphosulfate was added in GSH-fortified human liver cytosol (HLC). The formation of 3-GSH-NBP was 39.3-fold higher using 3-hydroxy-NBP (3-OH-NBP) as the substrate than NBP. The sulfotransferase (SULT) inhibitors DCNP (2,6-dichloro-4-nitrophenol) and quercetin suppressed 3-GSH-NBP formation in HLC by 75 and 82%, respectively, suggesting that 3-OH-NBP sulfation was involved in 3-GSH-NBP formation. Further SULT phenotyping revealed that SULT1A1 is the major isoform responsible for the sulfation. Dose-dependent toxicity was observed in primary rat hepatocytes exposed to 3-OH-NBP, with an IC50 of approximately 168 μM. Addition of DCNP and quercetin significantly increased cell viability, whereas l-buthionine-sulfoximine (a GSH depleter) decreased cell viability. Overall, our study revealed the underlying mechanism for the bioactivation of NBP is as follows. NBP is first oxidized to 3-OH-NBP and further undergoes sulfation to form 3-OH-NBP sulfate. The sulfate spontaneously cleaves off, generating highly reactive electrophilic cations, which can bind either to GSH to detoxify or to hepatocellular proteins to cause undesirable side effects.

Similar articles

• Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: Covalent protein adducts diminished by glutathione and N-acetylcysteine.

  Xue Y, Ren X, Zhu Z, Lei P, Liu M, Wan M, Zhong D, Huang H, Diao X. Xue Y, et al. Life Sci. 2021 Dec 15;287:120125. doi: 10.1016/j.lfs.2021.120125. Epub 2021 Nov 8. Life Sci. 2021. PMID: 34762904

• Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation.

  Diao X, Deng P, Xie C, Li X, Zhong D, Zhang Y, Chen X. Diao X, et al. Drug Metab Dispos. 2013 Feb;41(2):430-44. doi: 10.1124/dmd.112.049684. Epub 2012 Nov 20. Drug Metab Dispos. 2013. PMID: 23169608 Clinical Trial.

• In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.

  King RS, Teitel CH, Kadlubar FF. King RS, et al. Carcinogenesis. 2000 Jul;21(7):1347-54. Carcinogenesis. 2000. PMID: 10874013

• Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature.

  Pacifici GM. Pacifici GM. Int J Clin Pharmacol Ther. 2004 Sep;42(9):488-95. doi: 10.5414/cpp42488. Int J Clin Pharmacol Ther. 2004. PMID: 15487807 Review.

• Practical approaches to resolving reactive metabolite liabilities in early discovery.

  Dalvie D, Kalgutkar AS, Chen W. Dalvie D, et al. Drug Metab Rev. 2015 Feb;47(1):56-70. doi: 10.3109/03602532.2014.984813. Epub 2014 Nov 20. Drug Metab Rev. 2015. PMID: 25410913 Review.

Cited by

• New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.

  Diao X, Huestis MA. Diao X, et al. Front Chem. 2019 Mar 4;7:109. doi: 10.3389/fchem.2019.00109. eCollection 2019. Front Chem. 2019. PMID: 30886845 Free PMC article. Review.

• Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes.

  Diao X, Scheidweiler KB, Wohlfarth A, Zhu M, Pang S, Huestis MA. Diao X, et al. Forensic Toxicol. 2016;34:256-267. doi: 10.1007/s11419-016-0312-2. Epub 2016 Mar 28. Forensic Toxicol. 2016. PMID: 27547265 Free PMC article.

• Metabolism and Bioactivation of Fluorochloridone, a Novel Selective Herbicide, in Vivo and in Vitro.

  Shi J, Xie C, Liu H, Krausz KW, Bewley CA, Zhang S, Tang L, Zhou Z, Gonzalez FJ. Shi J, et al. Environ Sci Technol. 2016 Sep 6;50(17):9652-60. doi: 10.1021/acs.est.6b02113. Epub 2016 Aug 5. Environ Sci Technol. 2016. PMID: 27443216 Free PMC article.

• A Novel Fluorescence-Based Microplate Assay for High-Throughput Screening of hSULT1As Inhibitors.

  Niu X, Fan Y, Zou L, Ge G. Niu X, et al. Biosensors (Basel). 2024 May 27;14(6):275. doi: 10.3390/bios14060275. Biosensors (Basel). 2024. PMID: 38920579 Free PMC article.

• In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).

  Diao X, Carlier J, Zhu M, Pang S, Kronstrand R, Scheidweiler KB, Huestis MA. Diao X, et al. Forensic Toxicol. 2017 Jan;35(1):20-32. doi: 10.1007/s11419-016-0326-9. Epub 2016 Jul 6. Forensic Toxicol. 2017. PMID: 28286577 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations